Literature DB >> 20643578

Rigorous study of Xyrem®/sodium oxybate use among patients with obstructive sleep apnea and other conditions of compromised respiratory function is critically needed.

Deborah L Zvosec, Stephen W Smith, Mark W Mahowald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20643578     DOI： 10.1016/j.sleep.2010.04.003

Source DB:  PubMed          Journal:  Sleep Med        ISSN： 1389-9457            Impact factor:   3.492


× No keyword cloud information.
  1 in total

1.  Further research on Xyrem®/sodium oxybate treatment of patients with obstructive sleep apnea is needed.

Authors:  Deborah L Zvosec; Stephen W Smith; Mark W Mahowald
Journal:  Sleep Breath       Date:  2010-09-18       Impact factor: 2.816
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.